Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bio-Technology General and Serono promote growth:

This article was originally published in Clinica

Executive Summary

BioTechnology General is to co-market Serono Laboratories' line of paediatric growth products. This includes Geref Diagnostic, which detects the cause of a child's slow growth and can be used either prior to Geref treatment of idiopathic growth hormone deficiency in children, or as a stand-alone diagnostic agent. Geref, which consists of sermorelin acetate for injection, triggers the release of the body's available reserve of growth hormone. Bio-Technology is based in Iselin, New Jersey, while Serono Laboratories is based in Norwell, Massachusetts.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT081550

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel